BridgeMD
New treatment option for Cancer
Official title Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway
ClinicalTrials.gov ID: NCT07175376
What this study is testing
- What it's testing
- The study purpose is to gain a better understanding of the needs of adults aged 65 and older while they are receiving chemotherapy by measuring their resilience and tailor care plans based on their individual needs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Patients with cancer:
- Ability to understand and willingness to sign an IRB-approved informed consent
- Age ≥ 65 years at the time of enrollment.
- Planned to initiate an outpatient chemotherapy regimen (including myelosuppressive biologic/immune therapies) for cancer treatment (any type or...
- eFI pre-frail or frail status (available in EHR; defined as eFI \> 0.10) within 30 days before enrollment.
You likely can't join if
- Patients:
- Documented physical or psychological comorbidity that would limit participant's ability to understand or comply with study procedures for the entire...
- Chemotherapy planned at a facility outside the Atrium Health system.
- Currently receiving chemotherapy (defined as planned to continue an on-going treatment rather than starting a new regimen).
See the full eligibility criteria
- Patients with cancer:
- Ability to understand and willingness to sign an IRB-approved informed consent
- Age ≥ 65 years at the time of enrollment.
- Planned to initiate an outpatient chemotherapy regimen (including myelosuppressive biologic/immune therapies) for cancer treatment (any type or stage), either as an initial therapy or as a new line of therapy, with...
- eFI pre-frail or frail status (available in EHR; defined as eFI \> 0.10) within 30 days before enrollment.
- Ability to read and understand the English language Providers:
- Treating medical oncologist of at least one patient participant who enrolled on to the study and completed baseline assessment.
- Patients:
- Documented physical or psychological comorbidity that would limit participant's ability to understand or comply with study procedures for the entire length of the study per the enrolling investigator.
- Chemotherapy planned at a facility outside the Atrium Health system.
- Currently receiving chemotherapy (defined as planned to continue an on-going treatment rather than starting a new regimen).
The study team makes the final eligibility decision.
Where it's taking place
- Charlotte, North Carolina, United States
- Winston-Salem, North Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Charlotte, North Carolina, United States; Winston-Salem, North Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.